Michele Mari is Assistant Professor(RTD-B) in Medicinal Chemistry at University of Urbino, working in the field of natural products and melatonin receptor ligands.He achieved his Ph.D.in Chemical and Pharmaceutical Sciences in 2014 from the same university working on the strategic indole functionalization for the synthesis of tryptophan containing alkaloids and biologically active tryptamines.He spent 9 months at ETH Zurich as visiting researcher in the group of Prof.Jeffrey W. Bode working on the total synthesis of proteins.He spent 5 years as Postdoctoral Scientist at University of Urbino, in August 2019 he became Assistant Professor in Medicinal Chemistry, which is still his current position. In September 2017 he founded GLUOS with some colleagues, an innovative Startup and University Spinoff on the synthesis of molecules for medical devices and he is actually the President of the Board of Directors of the company. He is also member of the organizing committee of the European School of Medicinal Chemistry and EFMC-YSMC, Membe rof the communication teams of the EFMC and Medicinal Chemistry Division of the Italian Chemical Society, Memberof the Board of the Young Scientists Network of the EFMC.
Michele Mari is Assistant Professor(RTD-B) in Medicinal Chemistry at University of Urbino, working in the field of natural products and melatonin receptor ligands.He achieved his Ph.D.in Chemical and Pharmaceutical Sciences in 2014 from the same university working on the strategic indole functionalization for the synthesis of tryptophan containing alkaloids and biologically active tryptamines.He spent 9 months at ETH Zurich as visiting researcher in the group of Prof.Jeffrey W. Bode working on the total synthesis of proteins.He spent 5 years as Postdoctoral Scientist at University of Urbino, in August 2019 he became Assistant Professor in Medicinal Chemistry, which is still his current position. In September 2017 he founded GLUOS with some colleagues, an innovative Startup and University Spinoff on the synthesis of molecules for medical devices and he is actually the President of the Board of Directors of the company. He is also member of the organizing committee of the European School of Medicinal Chemistry and EFMC-YSMC, Membe rof the communication teams of the EFMC and Medicinal Chemistry Division of the Italian Chemical Society, Memberof the Board of the Young Scientists Network of the EFMC.